[1]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=2901091 [NCBI, ExPASy, EBI, Israel, Japan]
Ichinose A.,
Davie E.W.;
"Characterization of the gene for the a subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor.";
Proc. Natl. Acad. Sci. U.S.A. 85:5829-5833(1988).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA].
DOI=10.1021/bi00370a025; PubMed=3026437 [NCBI, ExPASy, EBI, Israel, Japan]
Ichinose A.,
Hendrickson L.E.,
Fujikawa K.,
Davie E.W.;
"Amino acid sequence of the a subunit of human factor XIII.";
Biochemistry 25:6900-6906(1986).
|
[3]
|
NUCLEOTIDE SEQUENCE [MRNA].
PubMed=2877457 [NCBI, ExPASy, EBI, Israel, Japan]
Grundmann U.,
Amann E.,
Zettlmeissl G.,
Kuepper H.A.;
"Characterization of cDNA coding for human factor XIIIa.";
Proc. Natl. Acad. Sci. U.S.A. 83:8024-8028(1986).
|
[4]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LEU-35; ILE-40; PHE-205; LEU-565; ILE-651 AND GLU-652.
Rieder M.J.,
Carrington D.P.,
Chung M.-W.,
Lee K.L.,
Poel C.L.,
Yi Q.,
Nickerson D.A.;
"SeattleSNPs. NHLBI HL66682 program for genomic applications, UW-FHCRC, Seattle, WA (URL: http://pga.gs.washington.edu).";
Submitted (SEP-2001) to the EMBL/GenBank/DDBJ databases.
|
[5]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLU-652.
TISSUE=Brain;
Totoki Y.,
Toyoda A.,
Takeda T.,
Sakaki Y.,
Tanaka A.,
Yokoyama S.,
Ohara O.,
Nagase T.,
Kikuno R.F.;
Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
|
[6]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLU-652.
TISSUE=Pancreas;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[7]
|
PROTEIN SEQUENCE OF 2-731.
PubMed=2877456 [NCBI, ExPASy, EBI, Israel, Japan]
Takahashi N.,
Takahashi Y.,
Putnam F.W.;
"Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta.";
Proc. Natl. Acad. Sci. U.S.A. 83:8019-8023(1986).
|
[8]
|
PROTEIN SEQUENCE OF 2-44.
DOI=10.1021/bi00701a018; PubMed=4811064 [NCBI, ExPASy, EBI, Israel, Japan]
Takagi T.,
Doolittle R.F.;
"Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin.";
Biochemistry 13:750-756(1974).
|
[9]
|
GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-614, AND MASS SPECTROMETRY.
TISSUE=Plasma;
DOI=10.1021/pr0502065; PubMed=16335952 [NCBI, ExPASy, EBI, Israel, Japan]
Liu T.,
Qian W.-J.,
Gritsenko M.A.,
Camp D.G. II,
Monroe M.E.,
Moore R.J.,
Smith R.D.;
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.";
J. Proteome Res. 4:2070-2080(2005).
|
[10]
|
X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS).
PubMed=7913750 [NCBI, ExPASy, EBI, Israel, Japan]
Yee V.C.,
Pedersen L.C.,
Trong I.L.,
Bishop P.D.,
Stenkamp R.E.,
Teller D.C.;
"Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII.";
Proc. Natl. Acad. Sci. U.S.A. 91:7296-7300(1994).
|
[11]
|
X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
DOI=10.1016/0049-3848(95)00072-Y; PubMed=7660355 [NCBI, ExPASy, EBI, Israel, Japan]
Yee V.C.,
Pedersen L.C.,
Bishop P.D.,
Stenkamp R.E.,
Teller D.C.;
"Structural evidence that the activation peptide is not released upon thrombin cleavage of factor XIII.";
Thromb. Res. 78:389-397(1995).
|
[12]
|
X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS).
DOI=10.1016/S0014-5793(98)00098-2; PubMed=9515726 [NCBI, ExPASy, EBI, Israel, Japan]
Weiss M.S.,
Metzner H.J.,
Hilgenfeld R.;
"Two non-proline cis peptide bonds may be important for factor XIII function.";
FEBS Lett. 423:291-296(1998).
|
[13]
|
X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
DOI=10.1074/jbc.274.8.4917; PubMed=9988734 [NCBI, ExPASy, EBI, Israel, Japan]
Fox B.A.,
Yee V.C.,
Pedersen L.C.,
le Trong I.,
Bishop P.D.,
Stenkamp R.E.,
Teller D.C.;
"Identification of the calcium binding site and a novel ytterbium site in blood coagulation factor XIII by X-ray crystallography.";
J. Biol. Chem. 274:4917-4923(1999).
|
[14]
|
POLYMORPHISM.
DOI=10.1007/BF00202857; PubMed=7913909 [NCBI, ExPASy, EBI, Israel, Japan]
Suzuki K.,
Iwata M.,
Ito S.,
Matsui K.,
Uchida A.,
Mizoi Y.;
"Molecular basis for subtypic differences of the 'a' subunit of coagulation factor XIII with description of the genesis of the subtypes.";
Hum. Genet. 94:129-135(1994).
|
[15]
|
VARIANT F13A DEFICIENCY HIS-682.
PubMed=1353995 [NCBI, ExPASy, EBI, Israel, Japan]
Board P.,
Coggan M.,
Miloszewski K.;
"Identification of a point mutation in factor XIII A subunit deficiency.";
Blood 80:937-941(1992).
|
[16]
|
CHARACTERIZATION OF VARIANT LEU-35.
PubMed=9763561 [NCBI, ExPASy, EBI, Israel, Japan]
Kangsadalampai S.,
Board P.G.;
"The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity.";
Blood 92:2766-2770(1998).
|
[17]
|
VARIANTS LEU-35; ILE-551; LEU-565; GLN-589; ILE-651 AND GLU-652.
DOI=10.1038/10290; PubMed=10391209 [NCBI, ExPASy, EBI, Israel, Japan]
Cargill M.,
Altshuler D.,
Ireland J.,
Sklar P.,
Ardlie K.,
Patil N.,
Shaw N.,
Lane C.R.,
Lim E.P.,
Kalyanaraman N.,
Nemesh J.,
Ziaugra L.,
Friedland L.,
Rolfe A.,
Warrington J.,
Lipshutz R.,
Daley G.Q.,
Lander E.S.;
"Characterization of single-nucleotide polymorphisms in coding regions of human genes.";
Nat. Genet. 22:231-238(1999).
|
[18]
|
ERRATUM.
Cargill M.,
Altshuler D.,
Ireland J.,
Sklar P.,
Ardlie K.,
Patil N.,
Shaw N.,
Lane C.R.,
Lim E.P.,
Kalyanaraman N.,
Nemesh J.,
Ziaugra L.,
Friedland L.,
Rolfe A.,
Warrington J.,
Lipshutz R.,
Daley G.Q.,
Lander E.S.;
Nat. Genet. 23:373-373(1999).
|
|
ExPASy Home page
